PP_1170x120_10-25-21

medication for migraine headaches

Glenmark cleared to market Frova generic

Glenmark cleared to market Frova generic

MUMBAI, India — Glenmark Pharmaceuticals USA has received approval from the Food and Drug Administration for frovatriptan succinate tablets 2.5 mg, a medication for migraine headaches. Glenmark said Monday that its product is a generic version of Frova tablets (2.5 mg) from Endo Pharmaceuticals Inc. Frova is indicated to help provide migraine pain relief and